{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:25:22Z","timestamp":1794335122857,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203788, 91643112"],"award-info":[{"award-number":["82203788, 91643112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203788, 91643112"],"award-info":[{"award-number":["82203788, 91643112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203788, 91643112"],"award-info":[{"award-number":["82203788, 91643112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02115-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:01:38Z","timestamp":1758880898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glutamine synthetase shields triple-negative breast cancer cells from ferroptosis in metastasis triggered by glutamine deprivation"],"prefix":"10.1186","volume":"27","author":[{"given":"Zhaoting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2115_CR1","doi-asserted-by":"crossref","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","DOI":"10.1038\/nrclinonc.2016.66"},{"key":"2115_CR2","doi-asserted-by":"crossref","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427\u201333.","DOI":"10.1016\/j.tibs.2010.05.003"},{"key":"2115_CR3","doi-asserted-by":"crossref","unstructured":"Deberardinis RJ, Cheng T. Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313\u201324.","DOI":"10.1038\/onc.2009.358"},{"key":"2115_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1083\/jcb.200703099","volume":"178","author":"M Yuneva","year":"2007","unstructured":"Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178:93\u2013105.","journal-title":"J Cell Biol"},{"issue":"2","key":"2115_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/genes9020108","volume":"9","author":"A Castegna","year":"2018","unstructured":"Castegna A, Menga A. Glutamine synthetase: localization dictates outcome. Genes (Basel). 2018;9(2):108.","journal-title":"Genes (Basel)"},{"key":"2115_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","volume":"24","author":"LA Timmerman","year":"2013","unstructured":"Timmerman LA, Holton T, Yuneva M, Louie RJ, Padr\u00f3 M, Daemen A, et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common Triple-Negative breast tumor therapeutic target. Cancer Cell. 2013;24:450\u201365.","journal-title":"Cancer Cell"},{"key":"2115_CR7","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/onc.2015.381","volume":"35","author":"M Van Geldermalsen","year":"2016","unstructured":"Van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, et al. ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35:3201\u20138.","journal-title":"Oncogene"},{"key":"2115_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75:544\u201353.","journal-title":"Cancer Res"},{"key":"2115_CR9","doi-asserted-by":"crossref","unstructured":"Kim GW, Lee DH, Jeon YH, Yoo J, Kim SY, Lee SW et al. Glutamine synthetase as a therapeutic target for cancer treatment. Int J Mol Sci. 2021;22(4):1701.","DOI":"10.3390\/ijms22041701"},{"key":"2115_CR10","doi-asserted-by":"crossref","unstructured":"Sohn BH, Park IY, Shin JH, Yim SY, Lee JS. Glutamine synthetase mediates Sorafenib sensitivity in \u03b2-catenin-active hepatocellular carcinoma cells. Exp Mol Med. 2018;50:e421.","DOI":"10.1038\/emm.2017.174"},{"key":"2115_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ncb2536","volume":"14","author":"KE n Der Vos","year":"2012","unstructured":"n Der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, Van Boxtel R, Putker M, et al. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol. 2012;14:829\u201337.","journal-title":"Nat Cell Biol"},{"key":"2115_CR12","first-page":"617","volume":"130","author":"T Kocher","year":"2000","unstructured":"Kocher T, Schraml P, Spagnoli GC, Harder F, Heberer M. Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activity. Schweiz Med Wochenschr. 2000;130:617\u201324.","journal-title":"Schweiz Med Wochenschr"},{"key":"2115_CR13","doi-asserted-by":"crossref","unstructured":"Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science (1979). 2017;358:941\u20136.","DOI":"10.1126\/science.aam9305"},{"key":"2115_CR14","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/jcb.25775","volume":"118","author":"Y Wang","year":"2017","unstructured":"Wang Y, Fan S, Lu J, Zhang Z, Wu D, Wu Z, et al. GLUL promotes cell proliferation in breast cancer. J Cell Biochem. 2017;118:2018\u201325.","journal-title":"J Cell Biochem"},{"key":"2115_CR15","doi-asserted-by":"crossref","unstructured":"Tyanova S, Albrechtsen R, Kronqvist P, Cox J, Mann M, Geiger T. Proteomic maps of breast cancer subtypes. Nat Commun 2016;7.","DOI":"10.1038\/ncomms10259"},{"key":"2115_CR16","doi-asserted-by":"crossref","unstructured":"Kung HN, Marks JR, Chi JT. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet. 2011;7.","DOI":"10.1371\/journal.pgen.1002229"},{"key":"2115_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1158\/1538-7445.AM2014-1416","volume":"74","author":"F Parlati","year":"2014","unstructured":"Parlati F, Demo SD, Gross MI, Janes JR, Lewis ER, MacKinnon AL, et al. Abstract 1416: CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies. Cancer Res. 2014;74:1416\u20131416.","journal-title":"Cancer Res"},{"key":"2115_CR18","doi-asserted-by":"crossref","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","DOI":"10.1016\/j.cell.2017.09.021"},{"key":"2115_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"2115_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"2115_CR21","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T et al. Association of the epithelial\u2013mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci. 2020;21(11):4002.","DOI":"10.3390\/ijms21114002"},{"key":"2115_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2\u2013YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature"},{"key":"2115_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354\u201363.","journal-title":"Mol Cell"},{"key":"2115_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"2115_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186\u201391.","journal-title":"Nature"},{"key":"2115_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","volume":"178","author":"C Wiel","year":"2019","unstructured":"Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, et al. BACH1 stabilization by antioxidants stimulates lung cancer metastasis. Cell. 2019;178:330\u201345.","journal-title":"Cell"},{"key":"2115_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cell.2019.06.003","volume":"178","author":"L Lignitto","year":"2019","unstructured":"Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1. Cell. 2019;178:316\u201329.","journal-title":"Cell"},{"key":"2115_CR28","doi-asserted-by":"crossref","unstructured":"Shui S, Zhao Z, Wang H, Conrad M, Liu G. Non-enzymatic lipid peroxidation initiated by photodynamic therapy drives a distinct ferroptosis-like cell death pathway. Redox Biol. 2021;45.","DOI":"10.1016\/j.redox.2021.102056"},{"key":"2115_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00432-016-2273-6","volume":"143","author":"Z Yang","year":"2017","unstructured":"Yang Z, Cui Y, Ni W, Kim S, Xuan Y. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143:243\u201354.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2115_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.yexcr.2018.10.006","volume":"373","author":"Z Yang","year":"2018","unstructured":"Yang Z, Zhang C, Qi W, Cui Y, Xuan Y. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K\/Akt\/NF\u03baB in colorectal adenocarcinoma. Exp Cell Res. 2018;373:145\u201354.","journal-title":"Exp Cell Res"},{"key":"2115_CR31","doi-asserted-by":"crossref","unstructured":"Tambay V, Raymond VA, Bilodeau M. Myc rules: leading glutamine metabolism toward a distinct cancer cell phenotype. Cancers (Basel). 2021;13(17):4484.","DOI":"10.3390\/cancers13174484"},{"key":"2115_CR32","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","volume":"20","author":"EM Palmieri","year":"2017","unstructured":"Palmieri EM, Menga A, Mart\u00edn-P\u00e9rez R, Quinto A, Riera-Domingo C, De Tullio G, et al. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep. 2017;20:1654\u201366.","journal-title":"Cell Rep"},{"key":"2115_CR33","doi-asserted-by":"crossref","unstructured":"Liu J, Song X, Kuang F, Zhang Q, Xie Y, Kang R et al. NUPR1 is a critical repressor of ferroptosis. Nat Commun. 2021;12.","DOI":"10.1038\/s41467-021-20904-2"},{"key":"2115_CR34","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1038\/onc.2017.146","volume":"36","author":"D Chen","year":"2017","unstructured":"Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene. 2017;36:5593\u2013608.","journal-title":"Oncogene"},{"key":"2115_CR35","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","volume":"77","author":"S Zhu","year":"2017","unstructured":"Zhu S, Zhang Q, Sun X, Zeh HJ, Lotze MT, Kang R, et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 2017;77:2064\u201377.","journal-title":"Cancer Res"},{"key":"2115_CR36","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/iub.271","volume":"61","author":"HO Jin","year":"2009","unstructured":"Jin HO, Seo SK, Woo SH, Choe TB, Hong S, Il, Kim J, Il, et al. Nuclear protein 1 induced by ATF4 in response to various stressors acts as a positive regulator on the transcriptional activation of ATF4. IUBMB Life. 2009;61:1153\u20138.","journal-title":"IUBMB Life"},{"key":"2115_CR37","doi-asserted-by":"crossref","unstructured":"Das BK, Wang L, Fujiwara T, Zhou J, Aykin-Burns N, Krager KJ et al. Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton. Elife. 2022;11.","DOI":"10.7554\/eLife.73539"},{"key":"2115_CR38","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117:31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2115_CR39","doi-asserted-by":"crossref","unstructured":"Bedke. Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression. Oncol Rep. 2009;23.","DOI":"10.3892\/or_00000617"},{"key":"2115_CR40","doi-asserted-by":"crossref","unstructured":"Wei MC, Zong WX, Cheng EHY, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science (1979). 2001;292:727\u201330.","DOI":"10.1126\/science.1059108"},{"key":"2115_CR41","doi-asserted-by":"crossref","unstructured":"Zuo S, Yu J, Pan H, Lu L. Novel insights on targeting ferroptosis in cancer therapy. Biomark Res. 2020;8:50.","DOI":"10.1186\/s40364-020-00229-w"},{"key":"2115_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138.","journal-title":"Nat Chem Biol"},{"key":"2115_CR43","doi-asserted-by":"crossref","unstructured":"Fang K, Du S, Shen D, Xiong Z, Jiang K, Liang D et al. SUFU suppresses ferroptosis sensitivity in breast cancer cells via hippo\/yap pathway. iScience. 2022;25(7):104618.","DOI":"10.1016\/j.isci.2022.104618"},{"key":"2115_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s42255-021-00524-2","volume":"4","author":"JS Zhao","year":"2022","unstructured":"Zhao JS, Shi S, Qu HY, Keckesova Z, Cao ZJ, Yang LX, et al. Glutamine synthetase licenses APC\/C-mediated mitotic progression to drive cell growth. Nat Metab. 2022;4:239\u201353.","journal-title":"Nat Metab"},{"key":"2115_CR45","doi-asserted-by":"crossref","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang C. yi, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12.","DOI":"10.1038\/s41467-021-25354-4"},{"key":"2115_CR46","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1039\/D1BM00622C","volume":"9","author":"Z Lin","year":"2021","unstructured":"Lin Z, Liu L, Wang W, Jia L, Shen Y, Zhang X, et al. The role and mechanism of polydopamine and cuttlefish ink melanin carrying copper ion nanoparticles in antibacterial properties and promoting wound healing. Biomater Sci. 2021;9:5951\u201364.","journal-title":"Biomater Sci"},{"key":"2115_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7150\/ijbs.7357","volume":"10","author":"J Li","year":"2014","unstructured":"Li J, Dong L, Wei D, Wang X, Zhang S, Li H. Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells. Int J Biol Sci. 2014;10:171\u201380.","journal-title":"Int J Biol Sci"},{"key":"2115_CR48","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13:890\u2013901.","journal-title":"Mol Cancer Ther"},{"key":"2115_CR49","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","volume":"5","author":"CD DiNardo","year":"2024","unstructured":"DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, et al. Glutaminase Inhibition in combination with Azacytidine in myelodysplastic syndromes: a phase 1b\/2 clinical trial and correlative analyses. Nat Cancer. 2024;5:1515\u201333.","journal-title":"Nat Cancer"},{"key":"2115_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neo.2019.10.004","volume":"22","author":"J Wappler","year":"2020","unstructured":"Wappler J, Arts M, R\u00f6th A, Heeren RMA, Peter Neumann U, Olde Damink SW, et al. Glutamine deprivation counteracts hypoxia-induced chemoresistance. Neoplasia. 2020;22:22\u201332.","journal-title":"Neoplasia"},{"key":"2115_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.20960\/nh.817","volume":"34","author":"BP Costa","year":"2017","unstructured":"Costa BP, Martins P, Ver\u00edssimo C, Sim\u00f5es M, Tom\u00e9 M, Grazina M, et al. Significado Pron\u00f3stico de La glutaminemia En Pacientes quir\u00fargicos cr\u00edticos. An\u00e1lisis Del perfil Del aminograma plasm\u00e1tico. Nutr Hosp. 2017;34:799\u2013807.","journal-title":"Nutr Hosp"},{"key":"2115_CR52","doi-asserted-by":"crossref","unstructured":"Yang Y, Ishak Gabra MB, Hanse EA, Lowman XH, Tran TQ, Li H et al. MiR-135 suppresses Glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1. Nat Commun. 2019;10.","DOI":"10.1038\/s41467-019-08759-0"},{"key":"2115_CR53","doi-asserted-by":"crossref","unstructured":"Leone RD, Zhao L, Englert JM, Sun IM, Oh MH, Sun IH et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science (1979). 2019;366:1013\u201321.","DOI":"10.1126\/science.aav2588"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02115-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:01:45Z","timestamp":1758880905000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02115-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6439513\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was approved by the institutional ethics committee of Air Force Medical Center, Air Force Medical University (approval no. 2024-69-PJ01). Written informed consent was obtained from each participant enrolled in the study. Peking University Health Science Center\u2019s Department of Animal Science approved the project license and all animal studies were conducted in compliance with institutional welfare guidelines (protocol n. LA2022256).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have consented to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}